Phase II Trial of a Simultaneous Radiochemotherapy with Cisplatinum and Paclitaxel in Combination with Hyperfractionated-Accelerated Radiotherapy in Locally Advanced Head and Neck Tumors

By  

Medical Oncology, Vol. 23, Iss. 3, 2006-09 ,pp. : 325-334

Humana Press, Inc

Access to resources Recommend Favorite

Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? – Results from the randomized DAHANCA 5 and 7 trials

By Hoff Camilla Molich   Lassen Pernille   Eriksen Jesper Grau   Hansen Hanne Sand   Specht Lena   Overgaard Marie   Grau Cai   Johansen Jørgen   Bentzen Jens   Andersen Lisbeth   Evensen Jan F.   Overgaard Jens  

Acta Oncologica, Vol. 50, Iss. 7, 2011-10 ,pp. : 1006-1014

Informa Healthcare

Access to resources Recommend Favorite

Lean body mass and muscle function in head and neck cancer patients and healthy individuals – results from the DAHANCA 25 study

By Lønbro Simon   Dalgas Ulrik   Primdahl Hanne   Johansen Jørgen   Nielsen Jakob Lindberg   Overgaard Jens   Overgaard Kristian  

Acta Oncologica, Vol. 52, Iss. 7, 2013-10 ,pp. : 1543-1551

Informa Healthcare

Access to resources Recommend Favorite

The value of routine follow-up after treatment for head and neck cancer. A National Survey from DAHANCA

By Pagh Anja  

Acta Oncologica, Vol. 52, Iss. 2, 2013-02 ,pp. : 277-284

Informa Healthcare

Access to resources Recommend Favorite

Benefits of Accelerated Hyperfractionation for Head and Neck Cancer

By Cummings Bernard J.  

Acta Oncologica, Vol. 38, Iss. 2, 1999-03 ,pp. : 131-135

Informa Healthcare

Access to resources Recommend Favorite